The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 26, 2018

Filed:

Mar. 26, 2015
Applicant:

National Health Research Institutes, Zhunan Town, TW;

Inventors:

Yen-Hung Chow, Zhunan Town, TW;

Yueh-Liang Tsou, Zhunan Town, TW;

Pele Choi-Sing Chong, Zhunan Town, TW;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C12N 15/861 (2006.01); C12N 15/00 (2006.01); A61K 38/00 (2006.01); C12N 15/63 (2006.01); A61K 39/125 (2006.01); A61K 39/12 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/125 (2013.01); A61K 39/12 (2013.01); A61K 2039/5252 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/5258 (2013.01); A61K 2039/542 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/57 (2013.01); C12N 2710/10323 (2013.01); C12N 2710/10343 (2013.01); C12N 2770/32323 (2013.01); C12N 2770/32334 (2013.01); C12N 2770/32351 (2013.01); C12N 2770/32371 (2013.01);
Abstract

The present invention relates to a recombinant adenoviral vector for generating immunity against enterovirus infection. In one embodiment, the recombinant adenoviral vector of the invention comprises an expression cassette encoding a PI protein and a 3 CD protease of an enterovirus. In another embodiment, the recombinant adenoviral vector of the invention comprises an expression cassette encoding a 3C protease or a 3CD protease of an enterovirus. The present invention also relates to a vaccine composition comprising the recombinant adenoviral vector as described. A method of inducing an immune response in a subject against enterovirus infection using the recombinant adenoviral vector and the vaccine composition is provided. Further provided is a method for producing virus like particles of an enterovirus by expressing the adenoviral vector as described herein in mammalian cells.


Find Patent Forward Citations

Loading…